TITLE

Advancing MS Treatments

PUB. DATE
May 2009
SOURCE
PN;May2009, Vol. 63 Issue 5, p18
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the progress of a research that aims to benefit the patients with multiple sclerosis (MS). It notes that the different organizations address awareness on MS and its treatment. It also mentions the different activities created by the National Multiple Sclerosis Society (NMSS) to celebrate the progress such as Walk MS and Bike MS.
ACCESSION #
37345172

 

Related Articles

  • Rec.om.mend\,re-ke-'mend\. Dugan, Mike // Inside MS;Fall98, Vol. 16 Issue 3, p70 

    Recommends drugs for the treatment of multiple sclerosis by the National Multiple Sclerosis (MS) Society. Physiologic action of the drugs; Why the drugs are recommended by the association; Groups that worked against MS.

  • Plan to speed studies of drug combinations.  // Inside MS;Summer98, Vol. 16 Issue 2, p37 

    Reports on the international task force convened by the National Multiple Sclerosis (MS) Society to study drug combinations for MS. Details on some of the drugs used to treat MS; Comments from Doctor Stephen Reingold, head of the Society's Research Programs.

  • Still a Mystery.  // Time; 

    The article focuses on the efforts of the U.S. National Multiple Sclerosis Society to find a cure for the disease. The author reports that the society has been raising funds and supporting research on multiple sclerosis since 1946. It says that 25 percent of the funds that the society has raised...

  • Advice on disease management revised and reaffirmed.  // Inside MS;Oct/Nov2005, Vol. 23 Issue 5, p37 

    Reports on the revision and reaffirmation of a Disease Management Consensus Statement issued by the Medical Advisory Board of the National MS Society to promote awareness of disease-modifying drugs, Avonex, Betaseron and Copaxone, to professionals and people with multiple sclerosis (MS). ...

  • C-Path, MS society form therapies consortium.  // Inside Tucson Business;12/14/2012, Vol. 22 Issue 28, p3 

    The article reports that Critical Path Institute or C-Path collaborated with the National Multiple Sclerosis Society for the launch of a consortium that will create new standards to evaluate results of clinical trials for multiple sclerosis (MS) therapies.

  • Access to the MS drugs. Dugan, Mike // Inside MS;Winter2000, Vol. 18 Issue 1, p70 

    Deals with the legislation and statement concerning the accessibility of Avonex, Betaseron or Copaxone drugs to physicians and people with multiple sclerosis in the United States. Information on the Consensus Statement on Disease Management issued by the National Multiple Sclerosis Society's...

  • Coming this May: National Teleconference on Treatment Options.  // Inside MS;Spring98, Vol. 16 Issue 1, p37 

    Announces the National Multiple Sclerosis Society's annual National Teleconference on Treatment Options slated for three weekends in May 1998. Event highlights; Sites set up across the country; Panelists for the event; Contact information.

  • Medical Marijuana and Multiple Sclerosis. Iliades, Christopher // Tennessee Tribune;12/17/2015, Vol. 26 Issue 51, p8B 

    The article discusses the treatment of multiple sclerosis (MS) by medical marijuana according to the National Multiple Sclerosis Society, mentions the symptoms that marijuana can help and consequences of using it.

  • The MS treatment team. Durand, Marcella // Momentum (19403410);Winter2008/2009, Vol. 2 Issue 1, p45 

    This article offers information on forming a multiple sclerosis (MS) treatment team. A person with MS may also assemble his or her own team using referrals from the National MS Society, from a primary care physician (PCP), or from a neurologist. But at the heart of any MS treatment team is a...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics